Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
about
Respiratory viruses other than influenza virus: impact and therapeutic advancesRespiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectivePreclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusComparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue.Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.Adenovirus infections in immunocompetent and immunocompromised patients.A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.Diagnostic value of respiratory virus detection in symptomatic children using real-time PCR.Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.The challenge of respiratory virus infections in hematopoietic cell transplant recipients.Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.Viral pneumonias in immunocompromised adult hosts.Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application.European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).Viral Respiratory Infections of Adults in the Intensive Care Unit.Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice.Epidemiology of adenovirus respiratory infections among hospitalized children in Seremban, Malaysia.Oncolytic viruses: the power of directed evolution.Late presentation of adenovirus-induced hemorrhagic cystitis and ureteral obstruction in a kidney-pancreas transplant recipient.Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis.In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.Rapid salvage treatment with virus-specific T cells for therapy-resistant disease.Anti-Viral Drugs for Human Adenoviruses.Successful outcome of a disseminated adenovirus infection 6 years after allogeneic bone marrow transplantation.Disseminated adenovirus disease in immunocompromised patient successfully treated with oral ribavirin: a case report.The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly.Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality
P2860
Q24655957-30328874-A3B9-462E-8058-69984E4C1A25Q26829188-01C6628C-B9A4-403A-906B-69985AA60591Q28388806-3D54DF20-6745-4A84-8D56-7DC4B1EC01A9Q33633287-0D5D0957-8340-469E-9E3C-E861E6D1E011Q33921073-14722629-7E4E-47EF-AE21-19F6FAFBA560Q33937843-360A32BB-020A-4FC5-89F0-07C757863965Q34036696-68625E21-81E1-4B2B-8DE6-B5A7B4B60A61Q34057627-2C236C1A-3A6F-48BC-8A2F-D132731A8C36Q34608885-BD39A692-0A4A-4D71-8E08-8853AB09824AQ36436697-BA9322C6-99E5-445C-89C6-9B9882D206F6Q37116929-A302E259-75D6-4250-8EA2-4348F1D8430CQ37266577-5DED54FB-4AAF-41ED-B98A-CB3EA251DF6BQ37316282-43E35898-7602-4DAD-B39A-981CB1BC1206Q37387693-F58FA1F1-9A35-4137-8524-85361A761701Q37505895-8A139441-94A4-4F2B-9934-84C6FFDC51DFQ37788451-B429D2A9-8016-42A8-AD51-B182BDC3CFC4Q37967604-3AB8E8C8-108F-44CE-9BF6-3602A694F010Q38059255-C69C7E9F-9C99-4472-925F-413D8AF23059Q38491990-7AC78FAB-B46E-4FDC-B71E-C1C12F2B7039Q38897929-52195CBA-CFA0-4D6E-B206-9BD6AEC6A90BQ40153232-E306954A-9A2C-4A26-BF6B-574C8F96889EQ40630931-772B99F2-AA19-40EF-BC7F-D3F3C29DDE1FQ40971576-B05F7A00-9CEE-44C8-81E9-814808D42240Q41555230-DA788077-067F-4028-8041-F81ABD25CD01Q45297004-C5872748-7E3E-45DB-AE34-F14A404A4E43Q45356159-DA24FBC9-9485-4723-B675-04E78326059AQ46103262-E5EDF2D0-F3C5-4664-9C9C-42B1A4C17F97Q46890999-38738153-33B0-4B58-B67A-5E4B85D5252BQ50554973-955793E2-F8BD-413A-955F-71199E734088Q52666285-0E169AA9-E00E-451D-876D-A702C6579B7DQ54441869-36B90F1D-687D-41B0-9307-9AB5C4F6E59CQ58449857-3197F2A7-A07C-40EC-BFBC-351924D73732
P2860
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
@ast
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
@en
type
label
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
@ast
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
@en
prefLabel
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
@ast
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
@en
P2093
P1476
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir
@en
P2093
Ambrish Ojha
Andres Ferber
Bijoyesh Mookerjee
Dolores Grosso
Janet Brunner
Joanne Filicko
John Wagner
Neal Flomenberg
Phyllis Flomenberg
Scott Dessain
P356
10.1016/J.BBMT.2006.08.040
P50
P577
2007-01-01T00:00:00Z